BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,392,000 | +30.1% | 51,484 | -0.2% | 0.01% | +25.0% |
| Q2 2022 | $2,607,000 | -61.4% | 51,610 | -51.2% | 0.00% | -50.0% |
| Q1 2022 | $6,760,000 | -76.0% | 105,829 | -59.8% | 0.01% | -76.5% |
| Q4 2021 | $28,190,000 | +4.2% | 263,185 | -0.1% | 0.03% | -10.5% |
| Q3 2021 | $27,062,000 | +17.1% | 263,462 | +0.2% | 0.04% | +22.6% |
| Q2 2021 | $23,117,000 | -16.4% | 262,809 | -7.6% | 0.03% | -24.4% |
| Q1 2021 | $27,648,000 | -73.8% | 284,352 | -69.8% | 0.04% | -50.6% |
| Q4 2020 | $105,530,000 | +346.4% | 940,980 | +269.0% | 0.08% | +93.0% |
| Q3 2020 | $23,639,000 | -41.9% | 255,000 | -51.1% | 0.04% | -47.6% |
| Q2 2020 | $40,669,000 | +35.7% | 521,403 | +1.8% | 0.08% | +12.3% |
| Q1 2020 | $29,959,000 | +73.7% | 512,297 | +137.9% | 0.07% | +114.7% |
| Q4 2019 | $17,250,000 | +34.7% | 215,366 | +23.5% | 0.03% | +25.9% |
| Q3 2019 | $12,810,000 | +46.9% | 174,350 | +88.6% | 0.03% | +42.1% |
| Q2 2019 | $8,721,000 | – | 92,456 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |